Skip to main content
SpringerLink
Log in

Neuro-Oncologic Complications of Lung Cancer

  • Chapter
Book cover Cancer Neurology in Clinical Practice

  • 166 Accesses

Abstract

Lung cancer is the most frequent form of cancer to be diagnosed in humans and is the leading cause of cancer-related mortality in the world. In the United States, it is the second leading cause of cancer in both men and women and is the number one cause of cancer-related mortality. In 1999, there were 171,600 new cases of lung cancer, comprising 14% of cancer diagnoses. The incidence is higher in men than women, but while the incidence rates of lung cancer among men have dropped by 2.5% since 1973, the incidence has increased among women by 123%. Concomitantly, mortality rates have been increasing in women more than men. The lifetime risk of developing lung cancer is 8.3% among female smokers and 14.6% among male smokers. Among ethnic groups, blacks have the highest incidence rates (117 per 100,000) while Native Americans have the lowest (14 per 100,000). Lung cancer rarely occurs before the age of 40, but thereafter a sharp increase in rates occurs. The median age at diagnosis is 65–70 yr.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Smith RA, Glynn TJ. Epidemiology of lung cancer. Radiolog Clin North Am 2000; 38: 453–470.

    Article  CAS  Google Scholar 

  2. Hoffman PC, Mauer AM, Vokes EV. Lung cancer. Lancet 2000; 355: 479–485.

    CAS  Google Scholar 

  3. Deslauriers J, Gregoire J. Surgical therapy of early non-small cell lung cancer. Chest 2000; 117: 104S - 109S.

    Article  CAS  PubMed  Google Scholar 

  4. Bunn PA, MaultJ, Kelly K. Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer. Chest 2000; 117: 119S - 1225.

    Article  CAS  PubMed  Google Scholar 

  5. Kelly K. New chemotherapy agents for small cell lung cancer. Chest 2000; 117: 156S - 162S.

    Article  CAS  PubMed  Google Scholar 

  6. Johnson DJ. Evolution of cisplatin-based chemotherapy in non-small cell lung cancer. Chest 2000; 117: 133S - 137S.

    Article  CAS  PubMed  Google Scholar 

  7. Curran WJ, Scott C, Langer C, et al. Phase III comparison of sequential vs concurrent chemoradiation for patients (Pts) with unresected stage III non-small cell lung cancer (NSCLC): initial report of radiation therapy oncology group (RTOG) 9410. Proc ASCO 2000; 19: 484a.

    Google Scholar 

  8. Elliot JA, Osterlind K, Hirsch FR, Hansen HH. Metastatic pattern in small-cell lung cancer. J Clin Oncol 1987; 5: 246–254.

    Google Scholar 

  9. Stenbygaard LE, Sorenson JB, Olsen JE. Metastatic pattern at autopsy in non-resectable adenocarcinoma of the lung. Acta Oncolog 1997; 36: 301–306.

    Article  CAS  Google Scholar 

  10. Postmus PE, Smit EF. Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 1999; 10: 753–759.

    Article  CAS  PubMed  Google Scholar 

  11. Glantz MJ, Choy H, Yee L. Prophylactic cranial irradiation in small cell lung cancer: rationale, results, and recommendations. Semin Oncol 1997; 24: 477–483.

    CAS  PubMed  Google Scholar 

  12. van Oosterhout AGM, van de Pol M, ten Velde GPM, Twijnstra A. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Cancer 1996; 77: 1434–1441.

    Article  CAS  PubMed  Google Scholar 

  13. Cole FH, Jr, Thomas JE, Wilcox AB, Halford HH. Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: Is it worthwhile? Ann Thorac Surg 1994; 57: 838–840.

    Article  PubMed  Google Scholar 

  14. Posner JB. Neurologic Complications of Cancer. F.A. Davis, Philadelphia, 1995.

    Google Scholar 

  15. Das A, Hochberg FH. Clinical presentation of intracranial metastases. Neurosurg Clin North Am 1996; 7: 377–391.

    CAS  Google Scholar 

  16. Ampil FL, Nanda A, Willis BK, et al. Metastatic disease in the cerebellum. The LSU experience in 1981–1993. Am J Clin Oncol 1996; 19: 509–511.

    Article  CAS  PubMed  Google Scholar 

  17. Nussbaum ES, Djalilian HR, Cjp KH. Brain metastases. Histology, multiplicity, surgery and survival. Cancer 1996; 78: 1781–1788.

    Article  CAS  PubMed  Google Scholar 

  18. Sumida M, Uozomi T, Kiya K, et al. Surface anatomy scanning (SAS) in intracranial tumors: comparison with surgical findings. Neuroradiology 1995; 37: 94–98.

    Article  CAS  PubMed  Google Scholar 

  19. Patchell R, Tibbs, PA, Walsh, JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494–500.

    Article  CAS  PubMed  Google Scholar 

  20. Pederson AG, Bach FW, Nissen M, Bach F. Creatine kinase BB and B-2-microglobulin as markers of CNS metastases in patients with small-cell lung cancer. J Clin Oncol 1985; 3: 1364–1372.

    Google Scholar 

  21. Pederson AG, Becker KL, Bach F, et al. Cerbrospinal fluid bombesin and calcition in patients with central nervous system metastases from small-cell lung cancer. J Clin Oncol 1986; 4: 1620–1627.

    Google Scholar 

  22. Wen PY, Loeffler JS. Management of brain metastases. Oncology 1999; 13: 941–961.

    CAS  PubMed  Google Scholar 

  23. Lagerwaard FJ, Levendag PC, Nowak PJCM, Eijkenboom WMH, Hanssens PEJ, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Rad Onc Biol Phys 1999; 43: 795–803.

    Article  CAS  Google Scholar 

  24. Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AOS. Pneumosystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 1991; 48: 406–409.

    Article  CAS  PubMed  Google Scholar 

  25. Nakagawa H, Miyawaki Y, Fujita T, et al. Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases. J of Neurol Neurosurg Psychiatry 1994; 57: 950–956.

    Article  CAS  Google Scholar 

  26. Shahidi H, Kvale PA. Long-term survival following surgical treatment of solitary brain metastasis in non-small cell lung cancer. Chest 1996; 109: 271–276.

    Article  CAS  PubMed  Google Scholar 

  27. Delattre J-Y, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol 1988; 45: 741–744.

    Article  CAS  PubMed  Google Scholar 

  28. Noordijk EM, Vecht CJ, Haaxma-Reiche HH, Padberg GW. The choice of treatment of single brain metastases should be based on extracranial tumor activity and age. Int J Rad Onc Biol Phys 1994; 29: 711–717.

    Article  CAS  Google Scholar 

  29. Wronski M, Arbit E, Burt M, Galicich JH. Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg 1995; 86: 605–616.

    Google Scholar 

  30. Bindal RK, Sawaya R, Leavens ME. Surgical treatment of multiple brain metastases. J Neurosurg 1993; 79: 210–216.

    Article  CAS  PubMed  Google Scholar 

  31. Hazuka MB, Burleson W, Stroud DN. Mulitple brain metastases are associates with poor survival in patients treated with surgery and radiotherapy. J Clin Oncol 1993; 11: 369–373.

    CAS  PubMed  Google Scholar 

  32. Arbit E, Wronski M, Burt M, Galicich JH. The treatment of patients with recurrent brain metastases. Cancer 1995; 76: 765–773.

    Article  CAS  PubMed  Google Scholar 

  33. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain. JAMA 1998; 280: 1485–1489.

    Article  CAS  PubMed  Google Scholar 

  34. Sen M, Ayse S, Detingoz R, et al. Prognostic factors in lung cancer with brain metastasis. Radiother Oncol 1998; 46: 33–38.

    Article  CAS  PubMed  Google Scholar 

  35. Postmus PE, Haaxma-Reiche H, Gregor A, et al. Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol 1998; 46: 29–32.

    Article  CAS  PubMed  Google Scholar 

  36. Kim, YS, Kondziolka D, Flickinger JC, Lundsford LD. Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain. Cancer 1997; 80: 2075–2803.

    Article  CAS  PubMed  Google Scholar 

  37. Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Nat Cancer Inst 1995; 87: 83–90.

    Google Scholar 

  38. Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1997; 33: 1752–1758.

    Article  CAS  PubMed  Google Scholar 

  39. Auperin A, Arrigado R, Pignon J-P, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 1999; 34: 476–484.

    Article  Google Scholar 

  40. Roman D, Sperduto P. Neuropsychologic effects of cranial radiation: current knowledge and future directions. Intl J Radiation Oncol Biol Physics 1995; 31: 983–998.

    Article  CAS  Google Scholar 

  41. Fonseca R, O’Neill BP, Foote RL, Grill JP, Sloan JA, Frytak S. Cerebral toxicity in patients treated for small cell carcinoma of the lung. Mayo Clin Proc 1999; 74: 461–465.

    CAS  PubMed  Google Scholar 

  42. Bunn PAJ, Kelly K. Prophylactic cranial irradiation for patients with small-cell lung cancer. J Nat Cancer Inst 1995; 87: 161–162.

    Article  PubMed  Google Scholar 

  43. Postmus P Haaxma-Reiche H, Smit E, et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy-a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 2000;18:3400–3408.

    Google Scholar 

  44. Wong WW, Schild SE, Sawyer TE, Shaw EG. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 1996; 34: 585–590.

    Article  CAS  PubMed  Google Scholar 

  45. Ryan GF, Ball DL, Smith JG. Treatment of brain metastases from primary lung cancer. Int J Radiat Oncol Biol Phys 1995; 31: 273–278.

    Article  CAS  PubMed  Google Scholar 

  46. Chamberlain MC, Kormanik P. Carcinomatous meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol 1998; 55: 506–512.

    Article  CAS  PubMed  Google Scholar 

  47. Zachariah B, Zachariah, S.B., R. Varghese, and L. Balducci. Carcinomatous meningitis: clinical manifestation and mangement. Intl J Clin Pharmacol Therapeut 1995; 33: 7–12.

    CAS  Google Scholar 

  48. Rosen ST, Aisner J, Makuch RW, et al. Carcinomatous leptomeningitis in small cell lung cancer. Medicine 1982; 61: 45–53.

    Article  CAS  PubMed  Google Scholar 

  49. Balducci L, Little DD, Khansur T, Steinberg MH. Carcinomatous meningits in small cell lung cancer. Am J Med Sci 1984; 287: 31–33.

    Article  CAS  PubMed  Google Scholar 

  50. Chamberlain MC. Leptomeningeal metastases: a review of evaluation and treatment. J Neuro-Oncol 1998; 37: 271–284.

    Article  CAS  Google Scholar 

  51. Boogerd W. Central nervous system metastasis in breast cancer. Radiother Oncol 1996; 40: 5–22.

    Article  CAS  PubMed  Google Scholar 

  52. Schaefer PW, Budzik RF, Gonzalez RG, et al. Imaging of cerebral metastases. Neurosurg Clin N Am 1996; 7: 393–423.

    CAS  PubMed  Google Scholar 

  53. Kallmes DF, Gray L, Glass JP. High-dose gadolinium-enhanced MRI for diagnosis of meningeal metastases. Neuroradiology 1998; 40: 23–26.

    Article  CAS  PubMed  Google Scholar 

  54. Fukui MB, Meltzer CC, Kanal E, Smirniotopoulos JG. MR imaging of the meninges. Part II. Neoplastic disease. Radiology 1996; 201: 605–612.

    CAS  PubMed  Google Scholar 

  55. Gomori JM, Heching N, Siegal T. Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging. J Neurooncol 1998; 36: 55–60.

    Article  CAS  PubMed  Google Scholar 

  56. Chamberlain MC. Spinal111lndium-DTPA CSF flow studies in leptomeningeal metastasis. J Neurooncol 1995; 25: 135–141.

    Article  CAS  PubMed  Google Scholar 

  57. Chamberlain MC, Kormanik PA. Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases. Neurology 1996; 46: 1674–1677.

    Article  CAS  PubMed  Google Scholar 

  58. Aboulafia DM, Taylor LP, Crane RD, JLY, Rudolph RH. Carcinomatous meningitis complicating cervical cancer: a clinicopathologic study and literature review. Gynecol Oncol 1996; 60: 313–318.

    Article  CAS  PubMed  Google Scholar 

  59. Garcia R, Bueno A, Castanon S, et al. Study of the DNA content by flow cytometry and proliferation in 281 brain tumors. Oncology 1997; 54: 112–117.

    Article  CAS  PubMed  Google Scholar 

  60. Chamberlain MC. New approaches to and current treatment of leptomeningeal metastases. Curr Opin Neurol 1994; 7: 492–500.

    Article  CAS  PubMed  Google Scholar 

  61. Milross CG, Davies MA, Fisher R, Mameghan J, Mameghan H. The efficacy of treatment for malignant epidural spinal cord compression. Australasian Radiol 1997; 41: 137–142.

    CAS  Google Scholar 

  62. Schiff D, Batchelor T, Wen PY. Neurologic emergencies in cancer patients. Neurol Clin 1998; 16: 449–483.

    Article  CAS  PubMed  Google Scholar 

  63. Bach F, Agerlin N, Sorensen JB, et al. Metastatic spinal cord compression secondary to lung cancer. J Clin Oncol 1992; 10: 1781 1787.

    Google Scholar 

  64. Goldman JM, Ash CM, Souhami RL, et al. Spinal cord compression in small cell lung cancer: A retrospective study of 610 patients. Br J Cancer 1989; 59: 591–593.

    Article  CAS  PubMed  Google Scholar 

  65. Bauer HCF. Posterior decompression and stabilization for spinal metastases. J Bone Joint Surg Intl 1997; 79: 514–522.

    CAS  Google Scholar 

  66. Klekamp J, Samii H. Surgical results for spinal metastases. Acta Neurochirurg (Wien) 1998; 140: 957–967.

    Article  CAS  Google Scholar 

  67. Schiff D, O’Neill BP, Wang C-H, O’Fallon JR. Neuroimaging and treatment implications of patients with multiple epidural spinal metastases. Cancer 1998; 83: 1593–1601.

    Article  CAS  PubMed  Google Scholar 

  68. Dethy S, Piccart MJ, Paesmans M, van Houtte P, Klastersky J. History of brain and epidural metastases from breast cancer in relation with the disease evolution outside the central nervous system. Eur Neurol 1995; 35: 38–42.

    Article  CAS  PubMed  Google Scholar 

  69. Bradley WG. Use of gadolinium chelates in MR imaging of the spine. J Magn Reson Imaging 1997; 7: 38–46.

    Article  CAS  PubMed  Google Scholar 

  70. Mehta RC, Marks MP, Hinks RS, Glover GH, Enzmann DR. MR evaluation of vertebral metastases: T1-weighted, short-inversiontime inversion recovery, fast spin-echo, and inversion-recovery fast spin-echo sequences. AJNR Am J Neuroradiol 1995; 16: 281–288.

    CAS  PubMed  Google Scholar 

  71. Twycross R. The risks and benefits of corticosteroids in advanced cancer. Drug Safety 1994; 11: 163–178.

    Article  CAS  PubMed  Google Scholar 

  72. van der Sande JJ, Boogerd W, Kappelle AC. Recurrent spinal epidural metastases: a prospective study with a complete follow up. J Neurol Neurosurg Psychiatry 1999; 66: 623–627.

    Article  CAS  PubMed  Google Scholar 

  73. Schiff D, Shaw EG, Cascino TL. Outcome after spinal reirradiation for malignant epidural spinal cord compression. Neurology 1995; 37: 583–589.

    CAS  Google Scholar 

  74. Ampil FL, Abreo F. Radiotherapeutic palliation of spinal epidural compression in small-cell lung cancer. Southern Med J 1992; 85: 266–269.

    Article  CAS  PubMed  Google Scholar 

  75. Schiff D, O’Neill BP. Intramedullary spinal cord metastases: clinical features and treatment outcome. Neurology 1996; 47: 906–912.

    Article  CAS  PubMed  Google Scholar 

  76. Weissman DE, Grossman SA. Simultaneous leptomeningeal and intramedullary spinal metastases in small cell lung carcinoma. Med Pediatr Oncol 1986; 14: 54–56.

    Article  CAS  PubMed  Google Scholar 

  77. Holoye P, Libnoch J, Cox J. Spinal cord metastasis in small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1984; 10: 349–356.

    Article  CAS  PubMed  Google Scholar 

  78. Newsom-Davis J. Paraneoplastic neurological disorders. J R Coll Physicians London 1999; 33: 225–227.

    CAS  Google Scholar 

  79. Posner JB, Dalmau JO. Paraneoplastic syndromes of the nervous system. Clin Chem Lab Med 2000; 38: 117–122.

    Article  CAS  PubMed  Google Scholar 

  80. Gutelkin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau JO. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumor association in 50 patients. Brain 2000; 123: 1481–1494.

    Article  Google Scholar 

  81. Greenlee JE. Cytotoxic T cells in paraneoplastic cerebellar degeneration. Ann Neurol 2000; 47: 4–5.

    Article  CAS  PubMed  Google Scholar 

  82. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-hu antibody in the serum of patients with small cell lung cancer: a quantitative western blot analysis. Ann Neurol 1990; 27: 544–552.

    Article  CAS  PubMed  Google Scholar 

  83. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB. The expression of the hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 1992; 141: 881–886.

    CAS  PubMed  Google Scholar 

  84. Grisold W, Drlicek M. Paraneoplastic neuropathy. Curr Opin Neurol 1999; 12: 617–625.

    Article  CAS  PubMed  Google Scholar 

  85. Das A, Hochberg FH, McNelis S. A review of the therapy of paraneoplastic neurologic syndromes. J Neuro-Oncol 1999; 41: 18 1194.

    Google Scholar 

  86. Jeyapalan SA, Batchelor TT. Diagnositic evaluation of neurologic metastases. Cancer Investig 2000; 18: 391–394.

    Article  Google Scholar 

Download references

Authors
  1. Suriya A. Jeyapalan MD,MA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John W. Henson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, University of Virginia Medical Center, Charlottesville, VA, USA

    David Schiff MD

  2. Center for Neuro-Oncology Dana-Farber Cancer Institute; and Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

    Patrick Y. Wen MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jeyapalan, S.A., Henson, J.W. (2003). Neuro-Oncologic Complications of Lung Cancer. In: Schiff, D., Wen, P.Y. (eds) Cancer Neurology in Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-317-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-317-0_20

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-4703-4

  • Online ISBN: 978-1-59259-317-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation